Johnson & Johnson New Covid-19 Vaccine

Johnson & Johnson has just received approval from the FDA for emergency use of their COVID-19 vaccine, making it the 3rd vaccine, and the first typical “viral vector” vaccine to treat COVID here in the United States. Johnson & Johnson joins Astrazeneca as a more traditional alternative to the Moderna and Pfizer mRNA vaccines approved for COVID. Traditional vaccines inject actual pieces of a virus, whether alive or dead, to elicit a response from our immune system, in order to create antibodies that will protect against future exposures. Unfortunately, this new option uses aborted fetal cell line PER.C6 cells created in 1985 from the retina of an 18 week old aborted human fetus in the development, production and testing of the vaccine. So, the Johnson & Johnson COVID-19 vaccine can/does contain actual fetal DNA fragments along with the weakened virus.

NCER opposes the use of human fetal tissue or cell lines taken from abortions because this is complicit with the immoral act of purposely destroying a human life. Not only is this unethical, but there is evidence that a vaccine derived from fetal cells could trigger long term autoimmune responses because our bodies see the combination of fetal human DNA and the virus as a biological enemy. Using Bioethics as our criteria, NCER recommends against receiving this new Johnson & Johnson COVID-19 vaccine if one has a choice. For those in the UK and Australia, we would include the Astrazeneca vaccine in this recommendation for the same reason.

For reported efficacy data and more information on the Johnson & Johnson vaccine, we are providing the following links:

Update: COVID-19 Vaccine Candidates and Abortion-Derived Cell Lines  – Charles Lozier Institute – Updated March 3, 2021

An Overview of the Johnson & Johnson COVID-19 Vaccine   – verywell health March 03, 2021



Leave a Reply

Your email address will not be published. Required fields are marked *